Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 34.63 M37.28 M38.83 M — Research & development 10.02 M10.3 M11.55 M — Operating income -4.34 M-2.51 M3.28 M — Non-Operating Income, Total -967 K-665 K1.88 M — Interest expense, net of interest capitalized 1.09 M353 K13 K — Non-Operating Income, excl. Interest Expenses -2.06 M-1.02 M1.86 M — Unusual income/expense ——— — Pretax income -5.31 M-3.18 M5.16 M — Equity in earnings ——— — Taxes 000 — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -5.31 M-3.18 M5.16 M — Discontinued operations ——— — Net income -5.31 M-3.18 M5.16 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -5.31 M-3.18 M5.16 M — Basic earnings per share (Basic EPS) -0.24-0.060.69 — Diluted earnings per share (Diluted EPS) -0.24-0.060.14 — Average basic shares outstanding 21.97 M57.66 M36.64 M — Diluted shares outstanding 21.97 M57.66 M36.64 M — EBITDA -4.24 M-2.41 M5.18 M — EBIT -4.34 M-2.51 M3.28 M — Cost of revenue 21.07 M22.96 M22.18 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 100 K100 K1.9 M —